Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Hurwitz

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Human Immunology|December 1, 1991
Cytotoxic activity of graft-infiltrating lymphocytes correlates with cellular rejection in cardiac transplant patientsD M Frisman, J T Fallon, A A Hurwitz, et al.
International Journal of Cancer|June 25, 1998
Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinomaA A Hurwitz, S E Townsend, T F Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapyE D Kwon, B A Foster, A A Hurwitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancerE D Kwon, A A Hurwitz, B A Foster, et al.
Cancer Research|May 16, 2000
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockadeA A Hurwitz, B A Foster, E D Kwon, et al.
Human Immunology|June 1, 1990
Clonal analysis of graft-infiltrating lymphocytes from renal and cardiac biopsies. Dominant rearrangements of TcR beta genes and persistence of dominant rearrangements in serial biopsiesD M Frisman, A A Hurwitz, W T Bennett, et al.
The Journal of Experimental Medicine|August 22, 2001
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapyA van Elsas, R P Sutmuller, A A Hurwitz, et al.
Oncogene|September 19, 2012
MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancerR S Hudson, M Yi, D Esposito, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Human Immunology|December 1, 1991
Cytotoxic activity of graft-infiltrating lymphocytes correlates with cellular rejection in cardiac transplant patientsD M Frisman, J T Fallon, A A Hurwitz, et al.
International Journal of Cancer|June 25, 1998
Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinomaA A Hurwitz, S E Townsend, T F Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapyE D Kwon, B A Foster, A A Hurwitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancerE D Kwon, A A Hurwitz, B A Foster, et al.
Cancer Research|May 16, 2000
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockadeA A Hurwitz, B A Foster, E D Kwon, et al.
Human Immunology|June 1, 1990
Clonal analysis of graft-infiltrating lymphocytes from renal and cardiac biopsies. Dominant rearrangements of TcR beta genes and persistence of dominant rearrangements in serial biopsiesD M Frisman, A A Hurwitz, W T Bennett, et al.
The Journal of Experimental Medicine|August 22, 2001
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapyA van Elsas, R P Sutmuller, A A Hurwitz, et al.
Oncogene|September 19, 2012
MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancerR S Hudson, M Yi, D Esposito, et al.
Pageof 2